# Supernus Pharmaceuticals, Inc.: filings

SUPN · Nasdaq · CIK 1356576 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/supn.md) · [Financials](/companies/supn/financials.md) · [Filings](/companies/supn/filings.md) · [Insiders](/companies/supn/insiders.md)

## Reports and events: 426 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 495, 8-K 311, 144 67, 10-Q 45, SC 13G/A 32, 3 26, 4/A 15, SC 13D/A 15, UPLOAD 15, 10-K 14, DEF 14A 14, DEFA14A 13, SC 13G 12, CORRESP 11, S-1/A 9, SCHEDULE 13G/A 9, ARS 7, CT ORDER 7, S-8 7, 8-K/A 6, SC 13D 6, 425 4, NT 10-K 4, NT 10-Q 4, SC TO-T/A 4, 10-Q/A 3, EFFECT 3, SCHEDULE 13G 3, SC TO-C 3, 424B4 2, 5 2, FWP 2, S-1 2, SC TO-T 2, 10-K/A 1, 3/A 1, 8-A12B 1, CERTNAS 1, D 1, D/A 1, DEFM14A 1, PRE 14A 1, S-3 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:12 ET | [10-Q](/filings/0001356576-26-000051.md) | Quarterly report, period 2026-09-30 | 0001356576-26-000051 |
| 2026-10-29 | 16:08 ET | [8-K](/filings/0001356576-26-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000050 |
| 2026-10-26 | 16:41 ET | [8-K](/filings/0001356576-26-000045.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001356576-26-000045 |
| 2026-10-22 | 21:07 ET | [8-K](/filings/0001104659-26-117937.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117937 |
| 2026-10-19 | 16:51 ET | [8-K](/filings/0001356576-26-000043.md) | 2.02 Results of operations | 0001356576-26-000043 |
| 2026-10-15 | 16:10 ET | [8-K](/filings/0001356576-26-000040.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-26-000040 |
| 2026-08-03 | 17:00 ET | [8-K](/filings/0001104659-26-089839.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089839 |
| 2026-08-03 | 08:34 ET | [8-K](/filings/0001104659-26-089524.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089524 |
| 2026-08-03 | 06:56 ET | [10-Q](/filings/0001356576-26-000037.md) | Quarterly report, period 2026-06-30 | 0001356576-26-000037 |
| 2026-08-03 | 06:46 ET | [8-K](/filings/0001356576-26-000035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000035 |
| 2026-08-03 | 06:43 ET | [8-K](/filings/0001104659-26-089425.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-089425 |
| 2026-07-22 | 17:07 ET | [8-K](/filings/0001356576-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000031 |
| 2026-06-18 | 16:55 ET | [8-K](/filings/0001356576-26-000028.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-26-000028 |
| 2026-05-20 | 16:37 ET | [8-K](/filings/0001356576-26-000025.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001356576-26-000025 |
| 2026-05-05 | 16:15 ET | [10-Q](/filings/0001356576-26-000022.md) | Quarterly report, period 2026-03-31 | 0001356576-26-000022 |
| 2026-05-05 | 16:09 ET | [8-K](/filings/0001356576-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000020 |
| 2026-04-30 | 17:00 ET | [DEF 14A](/filings/0001104659-26-053111.md) | Proxy statement, period 2026-06-18 | 0001104659-26-053111 |
| 2026-04-22 | 16:32 ET | [8-K](/filings/0001356576-26-000015.md) | 2.02 Results of operations | 0001356576-26-000015 |
| 2026-04-07 | 17:25 ET | [8-K](/filings/0001104659-26-040497.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-26-040497 |
| 2026-03-02 | 16:40 ET | [10-K](/filings/0001356576-26-000011.md) | Annual report, period 2025-12-31 | 0001356576-26-000011 |
| 2026-02-24 | 16:22 ET | [8-K](/filings/0001356576-26-000007.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001356576-26-000007 |
| 2026-02-24 | 16:13 ET | [8-K](/filings/0001356576-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000004 |
| 2026-02-12 | 16:16 ET | [8-K](/filings/0001356576-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-26-000002 |
| 2026-01-28 | 17:28 ET | [8-K](/filings/0001628280-26-003907.md) | 9.01 Financial statements and exhibits | 0001628280-26-003907 |
| 2025-11-06 | 17:01 ET | [10-Q](/filings/0001356576-25-000071.md) | Quarterly report, period 2025-09-30 | 0001356576-25-000071 |
| 2025-11-04 | 16:17 ET | [8-K](/filings/0001356576-25-000068.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001356576-25-000068 |
| 2025-10-21 | 17:05 ET | [8-K](/filings/0001356576-25-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000065 |
| 2025-10-16 | 16:11 ET | [8-K/A](/filings/0001356576-25-000062.md) | 9.01 Financial statements and exhibits | 0001356576-25-000062 |
| 2025-08-05 | 16:24 ET | [10-Q](/filings/0001356576-25-000055.md) | Quarterly report, period 2025-06-30 | 0001356576-25-000055 |
| 2025-08-05 | 16:18 ET | [8-K](/filings/0001356576-25-000053.md) | 2.02 Results of operations | 0001356576-25-000053 |
| 2025-08-04 | 18:04 ET | [8-K](/filings/0001356576-25-000050.md) | 5.02 Departure or appointment of officers or directors | 0001356576-25-000050 |
| 2025-07-31 | 08:58 ET | [8-K](/filings/0001104659-25-072506.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072506 |
| 2025-07-22 | 16:30 ET | [8-K](/filings/0001356576-25-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000046 |
| 2025-06-17 | 16:40 ET | [8-K](/filings/0001356576-25-000042.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001356576-25-000042 |
| 2025-06-16 | 08:34 ET | [8-K](/filings/0001104659-25-059687.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059687 |
| 2025-05-28 | 16:09 ET | [8-K](/filings/0001356576-25-000038.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000038 |
| 2025-05-06 | 16:20 ET | [10-Q](/filings/0001356576-25-000033.md) | Quarterly report, period 2025-03-31 | 0001356576-25-000033 |
| 2025-05-06 | 16:14 ET | [8-K](/filings/0001356576-25-000031.md) | 2.02 Results of operations | 0001356576-25-000031 |
| 2025-04-30 | 16:17 ET | [DEF 14A](/filings/0001104659-25-042531.md) | Proxy statement, period 2025-06-16 | 0001104659-25-042531 |
| 2025-04-23 | 17:20 ET | [8-K](/filings/0001356576-25-000020.md) | 2.02 Results of operations | 0001356576-25-000020 |
| 2025-02-25 | 16:13 ET | [10-K](/filings/0001356576-25-000017.md) | Annual report, period 2024-12-31 | 0001356576-25-000017 |
| 2025-02-25 | 16:06 ET | [8-K](/filings/0001356576-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000015 |
| 2025-02-24 | 16:13 ET | [8-K](/filings/0001356576-25-000011.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001356576-25-000011 |
| 2025-02-18 | 16:35 ET | [8-K](/filings/0001356576-25-000008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000008 |
| 2025-02-11 | 17:13 ET | [8-K](/filings/0001356576-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-25-000006 |
| 2025-02-04 | 16:23 ET | [8-K](/filings/0001356576-25-000004.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000004 |
| 2025-01-27 | 16:20 ET | [8-K](/filings/0001356576-25-000002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001356576-25-000002 |
| 2024-12-20 | 16:10 ET | [8-K](/filings/0001356576-24-000069.md) | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001356576-24-000069 |
| 2024-11-04 | 16:19 ET | [10-Q](/filings/0001356576-24-000067.md) | Quarterly report, period 2024-09-30 | 0001356576-24-000067 |
| 2024-11-04 | 16:13 ET | [8-K](/filings/0001356576-24-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001356576-24-000065 |

Page 1 of 9. [Older](/companies/supn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:38 ET. No prices; not investment advice.